Search clinical trials for: Iopamidol 370

Total 4009 results

Contineum Therapeutics

Recruiting

Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis (VISTA)

Relapsing Remitting Multiple Sclerosis

United States
Novo Nordisk A/S

Completed

Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

Diabetes Mellitus, Type 2 | Diabetes

Hungary
Novo Nordisk A/S

Completed

Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes (IMPROVE Life)

Diabetes Mellitus, Type 2 | Diabetes

India
Novo Nordisk A/S

Completed

Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Norway, Sweden
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®

Diabetes Mellitus, Type 2 | Diabetes

Tunisia
Guerbet

Terminated

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography (CINOPSIS CT)

Renal Impairment

United States
Bausch Health Americas, Inc.

Completed

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg

Healthy

United States
Stony Brook University

Completed

Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS (MSCycling)

Multiple Sclerosis

United States
University Hospitals, Leicester
Jafron Biomedical Company Limited

Not yet recruiting

Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support. (HACEC)

Inflammation | Acute Kidney Injury | ARDS | Extracorporeal Circulation; Complications

United Kingdom
Valbiotis
University Hospital, Clermont-Ferrand

Terminated

Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio-metabolic Risk (OLALIP)

Atherosclerosis | Dyslipidemias | Hypercholesterolemia | Cardiovascular Risk Factor | Cardio-metabolic Risk

France
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, Australia, Poland, New Zealand, Spain, Georgia, United Kingdom, Bulgaria, Czechia, Romania
Amgen

Terminated

A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies

Myelodysplastic Syndrome | Relapsed/Refractory AML | Minimal Residual Disease Positive AML

United States, Canada, Germany, Netherlands
Protagonist Therapeutics, Inc.

Completed

Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers

Healthy Volunteers

Australia
Curis, Inc.

Completed

A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

Advanced Solid Tumors or Lymphomas

United States, Spain, Korea, Republic of, United Kingdom
Careseng Biotech Co., Ltd.

Unknown

Careseng 1370 for Healthy Volunteers

Chemotherapy-induced Myelosuppression
Chang Gung University
Chang Gung Memorial Hospital

Completed

The Impact of Exergame on User Health

Impact of Exergame Use on User Health

Taiwan
IDEA AG

Completed

Effect of IDEA-070 on Pain and Inflammation Induced by PDT

Actinic Keratosis

Germany
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

Type II Diabetes

Korea, Republic of
Karyopharm Therapeutics Inc

Terminated

Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas (STARRS)

Squamous Cell Carcinoma

United States, Canada
Novartis Pharmaceuticals

Completed

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis (VIP-S)

Chronic Plaque Psoriasis

United States
Novo Nordisk A/S

Completed

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment (Start)

Diabetes Mellitus, Type 2 | Diabetes

Finland
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes (EFFECTIVE)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Former Serbia and Montenegro
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Diabetes Mellitus, Type 2 | Diabetes

China
Frontier Medicines Corporation

Recruiting

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors (PROSPER)

Colorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Unresectable Solid Tumor | KRAS G12C | Advanced Solid Tumors With KRAS G12C Mutations

United States
Hunan Province Tumor Hospital

Recruiting

Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

Advanced Solid Tumors or Lymphomas

China
Karolinska Institutet

Recruiting

Large Scale Implementation of MINISTOP 3.0

Obesity, Child

Sweden
Rise Therapeutics LLC
University of Colorado, Denver; Mayo Clinic

Recruiting

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic Mild

United States
Coordination Pharmaceuticals, Inc.

Completed

Phase I Study of CPI-300 in Patients With Advanced Tumors (CPI-300)

Advanced Tumors

United States
LMU Klinikum
Peter Young Neurological Clinic Medicalpark Bad Feilnbach, Germany

Completed

Effects of BIONESS in Rehabilitation of Stroke (EFES-BIO-SEP)

Stroke

Germany
ModernaTX, Inc.

Withdrawn

Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia

Metabolism, Inborn Errors | Methylmalonic Acidemia (MMA)
Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company

Withdrawn

Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease

Niemann-Pick Disease, Type C
Hebrew SeniorLife

Completed

Power V360 - Promoting Optimal Wellness Among Elders Through Vitalize 360

Health, Subjective
Virobay Inc.

Completed

Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults

Chronic Hepatitis C Infection

United States
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Myasthenia Gravis

China
Resurge Therapeutics Inc.

Recruiting

RT-310 Dose Escalation BPH Study

Lower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)

New Zealand, Australia
Optinose US Inc.

Recruiting

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Bilateral Nasal Polyposis

United States
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps

Chronic Rhinosinusitis

United States, United Kingdom, Bulgaria, Canada, Georgia, Poland, Russian Federation, Sweden
Pipeline Therapeutics, Inc.

Completed

PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers

Multiple Sclerosis

United Kingdom
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study On Human Mass Balance And Biotransformation

Healthy Adult Subjects

China
Protagonist Therapeutics, Inc.

Completed

Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia (TRANSCEND)

Chronic Anemia | β-thalassemia | Ineffective Erythropoiesis

United States, Malaysia, Turkey, Thailand, United Kingdom, Italy, Lebanon, Tunisia, Greece
Great Lakes NeuroTechnologies Inc.
Johns Hopkins University; The Cleveland Clinic; National Institute on Aging (NIA) and other collaborators

Completed

Kinesia 360 Parkinson's Monitoring Study

Parkinson's Disease

United States
Biotronik AG

Completed

First in Man Trial - BIOSOLVE-I (BIOSOLVE-I)

de Novo Lesions in Native Coronary Arteries

Netherlands, Switzerland, Germany, Belgium
Novo Nordisk A/S

Completed

Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
Alebund Pharmaceuticals

Completed

A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants

Healthy Subjects

China
Novo Nordisk A/S

Completed

Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

Diabetes Mellitus, Type 2 | Diabetes

Israel
Mansoura University

Completed

14.0- 3.0- 3.0- η Protein With Rheumatoid Arthritis

Disease Activity

Egypt
Astex Pharmaceuticals, Inc.

Completed

Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid Malignancies

Solid Tumors

United States
King Abdullah International Medical Research Center
Novartis

Terminated

Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy (NISRI)

Myeloid Leukemia, Chronic

Saudi Arabia

Search clinical trials for: Iopamidol 370

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations